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chondrocyte signaling pathways. We focus our attention on 
two major areas: age-dependent alterations in transforming 
growth factor-β signaling and changes in protein kinase and 
phosphoprotein phosphatase activities in aging chondro-
cytes. A better understanding of the basic signaling mecha-
nisms underlying aging in chondrocytes is likely to facilitate 
the development of new therapeutic and preventive strate-
gies for OA and a range of other age-related osteoarticular 
disorders.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Aging is a risk factor for a variety of chronic health 
problems, including cancer, diabetes, cardiovascular and 
neurodegenerative disorders. Advancing age is also a ma-
jor risk factor for the development of arthritic and mus-
culoskeletal diseases. Osteoarthritis (OA) is an age-relat-
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 Abstract 
 Musculoskeletal conditions are a major burden on individu-
als, healthcare systems, and social care systems throughout 
the world, with indirect costs having a predominant eco-
nomic impact. Aging is a major contributing factor to the 
development and progression of arthritic and musculoskel-
etal diseases. Indeed, aging and inflammation (often re-
ferred to as ‘inflammaging’) are critical risk factors for the 
development of osteoarthritis (OA), which is one of the most 
common forms of joint disease. The term ‘chondrosenes-
cence’ has recently been introduced to define the age-de-
pendent deterioration of chondrocyte function and how it 
undermines cartilage function in OA. An important compo-
nent of chondrosenescence is the age-related deregulation 
of subcellular signaling pathways in chondrocytes. This 
mini-review discusses the role of age-related alterations in 
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ed disease of synovial joints. It is characterized by the pro-
gressive deterioration and loss of articular cartilage with 
concomitant structural and functional changes in the en-
tire synovial joint, including the synovium, periarticular 
ligaments, and subchondral bone. OA is actually one of 
the most common, costly, and disabling forms of joint 
disease, being far more common than rheumatoid arthri-
tis, psoriatic arthritis, and other forms of joint disease. 
Age, obesity, and metabolic disease are major risk factors 
for the development of OA. Traditionally, OA was con-
sidered a noninflammatory ‘wear and tear’ disease. How-
ever, over the last few decades, this outdated view has 
been challenged with solid scientific and clinical evi-
dence. OA is now generally accepted to be an inflamma-
tory and biomechanical whole-organ disease that is influ-
enced by a number of factors including ‘inflammaging’. 
One of the hallmarks of inflammaging is cellular senes-
cence. Evidence from the published literature supports 
the concept that ‘chondrocyte senescence’ or ‘chondrose-
nescence’ affects the functional phenotype of the cells, is 
intimately linked with ‘inflammaging’, and is involved in 
the pathogenesis and progression of OA  [1] ( fig. 1 ). This 
paper focuses on aging of chondrocytes in OA and the 
role of age-related alterations in chondrocyte signaling 
pathways. We turn our attention to the molecular mech-
anisms and subcellular pathways implicated in chondro-
cyte aging. We discuss two major areas of research: age-
dependent alterations in transforming growth factor-β 
(TGF-β) signaling and changes in protein kinase and 
phosphoprotein phosphatase activities in aging chondro-
cytes and review the evidence supporting changes in these 
processes.
 Age-Dependent Alterations in TGF-β Signaling in OA 
 Active TGF-β signaling is vital for the physiological 
maintenance of articular cartilage. Binding of TGF-β to its 
constitutively active type II receptor recruits the type I re-
ceptor, and the latter is thereafter phosphorylated and ac-
tivated, a process that is necessary for TGF-β-mediated 
responses. The crucial role of active TGF-β signaling is 
highlighted by the promotion of chondrocyte hypertro-
phic differentiation and early OA development in mice 
expressing a truncated, kinase-defective TGF-β type II re-
ceptor in skeletal tissue  [2] . Moreover, the TGF-β signal-
ing protein Smad3 is absolutely essential for blocking hy-
pertrophy in articular chondrocytes, both in mice and 
men  [3, 4] . The presence of normal TGF-β signaling is 
crucial for the maintenance of articular cartilage; howev-
er, exposure of joint tissues in animal models to high ac-
tive TGF-β levels leads to osteophyte formation, synovial 
fibrosis and most likely contributes to joint pain  [5–8] .
 Crystals are common in OA joints and are thought to 
contribute to cartilage degradation and joint inflamma-
tion  [9] . Moreover, increased mineralization of the carti-
lage matrix can occur in OA  [10] . TGF-β is a known stim-
ulant of inorganic pyrophosphate, a molecule essential 
for crystal formation. Work on porcine explants has 
shown that TGF-β strongly stimulates inorganic pyro-
phosphate elaboration in aged cartilage compared to 
young tissue  [11] . A similar finding was reported com-
paring different human age groups (15–55 and 56–91 
years)  [12] . These results indicate that age-dependent 
changes in TGF-β responsiveness might contribute to 
crystal formation in aging joints.
 Binding of TGF-β to its type II receptor results in the 
recruitment and phosphorylation of a type I receptor. In 
chondrocytes, TGF-β not only signals via the canonical type 
I receptor ALK5 (TGFBR1) but also via the ALK1 (ACVRL1) 
receptor  [13, 14] . Signaling via ALK5 leads to activation of 
the Smad2/3 route, while ALK1 phosphorylation activates 
the Smad1/5/8 pathway. Using in vitro models, it has been 
shown that augmented expression of ALK1 increases ma-
trix metalloproteinase-13 (MMP13) expression, while its 
inhibition reduces MMP13 expression. Moreover, reduced 
ALK5 expression elevates MMP13 expression levels. In hu-
man OA cartilage, ALK1 expression levels correlate posi-
tively with MMP13 expression  [13] . These data indicate 
Osteoarthritis
Chondrosenescence
Inflammaging
 Fig. 1. Aging, inflammaging, and chondrosenescence in OA. 
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that the balance between ALK5 and ALK1 is crucial to 
maintain cartilage homeostasis and that loss of ALK5 sig-
naling will result in loss of cartilage integrity.
 In classic murine studies carried out in the 1990s, the 
important observation was made that TGF-β effects on 
old cartilage are different from those on young cartilage 
 [15] . TGF-β is able to counteract the effects of proinflam-
matory cytokine interleukin-1β (IL-1β) only in cartilage 
of young mice  [16] . Aging is associated with a decreased 
expression of both ALK5 and phosphorylated Smad2/3 in 
articular cartilage which was in line with the observation 
that TGF-β does not block IL-1 effects in aged cartilage 
 [17] . Since TGF-β can signal via either ALK5 or ALK1, 
investigation of the age-related changes in expression of 
ALK5 and ALK1 revealed that the ALK1/ALK5 ratio is 
significantly increased in old C57Bl/6 mice compared to 
young, favoring TGF-β signaling via the Smad1/5/8 route 
and the differentiation of chondrocytes into cells with an 
autolytic phenotype  [13] . This observed change in the 
ALK1/ALK5 ratio has also been confirmed by others, for 
instance in the C57/BL1/6 (ICRFa) mouse strain and 
Dunkin-Hartley guinea pigs  [18, 19] . The latter study  [19] 
also demonstrated a progressive switch of the expression 
of phosphorylated Smad2/3 to Smad1/5/8 in old animals.
 Loading of articular cartilage is absolutely essential for 
its physiological maintenance. Reduced joint loading 
leads to cartilage degeneration, both in humans and ani-
mal models, and patients with spinal cord injuries exhib-
it progressive loss of knee cartilage. Loading of chondro-
cytes has been shown to activate Smad2/3 signaling in 
these cells  [20] . Compressive loading of bovine cartilage 
explants upregulates the expression of Smad2/3 response 
genes bSerpine1, bSmad7, and bAlk5 while the expres-
sion of the Smad1/5/8 responsive gene Id1 is downregu-
lated  [21] . However, when comparing the responsiveness 
of young (6–36 months) and old (6–13 years) bovine car-
tilage, it was found that aged cartilage showed a highly 
reduced capacity for mechanically mediated activation of 
Smad2/3P signaling when compared to young cartilage 
 [22] . This reduced responsiveness can be a result of a stiff-
er matrix of old cartilage which makes it harder to me-
chanically activate TGF-β signaling, or is the consequence 
of an age-related reduction in expression of ALK5, as is 
observed in aged bovine cartilage. It can also be that re-
duced ALK5 expression itself is the result of a stiffer ma-
trix, since ALK5 expression is regulated by active TGF-β 
signaling. Irrespective of the underlying cause, it can be 
expected that an age-related decrease in TGF-β signaling 
(Smad2/3) might impair cartilage preservation, since in-
tact Smad2/3 signaling is crucial for healthy cartilage. The 
age-related loss of Smad2/3 signaling can be considered a 
normal part of the aging process, but this can make ar-
ticular cartilage more vulnerable to OA development at 
an advanced age compared to young individuals.
 A very interesting observation with regard to TGF-β 
signaling and OA is the relationship between aging and 
circadian rhythms. Aging is associated with a loss of the 
normal circadian rhythm  [23] . Recent studies have dem-
onstrated that expression of the core clock transcription 
factor BMAL1 is disrupted in human OA cartilage and in 
aged mouse cartilage  [24] . Deficiency of BMAL1 in mice 
reduced the levels of phosphorylated Smad2/3 but in-
creased phosphorylated Smad1/5/8 levels. These results 
link aging and loss of the circadian rhythm to a shift in 
the ALK5/ALK1 ratio, which may be related to a loss of 
articular cartilage homeostasis and OA. All above-de-
scribed observations point to a role of age-related chang-
es in TGF-β signaling as a driving force of chondrocyte 
hypertrophy and OA development and progression.  Fig-
ure 2 summarizes the alterations in TGF-β, ALK1/5, and 
Smad1/5/8 pathways in chondrosenescence and OA.
 Alterations in Protein Kinase and Phosphoprotein 
Phosphatase Activities in Aging Chondrocytes 
 Reversible protein phosphorylation on specific Ser/
Thr residues regulated by the balanced activities of pro-
tein kinases and phosphoprotein phosphatases is a key 
process that controls all stages and aspects of the chon-
drocyte life cycle in response to extracellular stimuli  [25, 
26] . Amongst the key chondrocyte signaling pathways are 
protein kinase A, protein kinase C, mitogen-activated 
protein kinases (MAPKs, such as p38, JNK, and ERK), the 
phosphoinositide-3 kinase (PI3K)/Akt pathway, as well 
as protein phosphatase 1A (PP1A), PP2A, and calcineu-
rin (PP2B)  [27] . Accumulating evidence suggests that 
some of these signaling pathways are differentially regu-
lated during the aging process in chondrocytes. It is gen-
erally accepted that reactive oxygen species (ROS) con-
tribute to senescence not only by causing direct damage 
to proteins, lipids, and DNA, but also by modulating cell 
signaling pathways that promote senescence through ac-
tivation of redox-sensitive kinases and inhibition of re-
dox-sensitive phosphatases  [28] . Increased ROS levels 
can also upregulate proinflammatory cytokines and 
MMPs, factors that coconspire and mediate cartilage ma-
trix degradation  [29] . Given their central role in chondro-
senescence  [1] , age-related alterations in the MAPK path-
ways are likely to be particularly important. Several stud-
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ies have suggested the involvement of MAPKs in 
mediating chondrosenescence. Caveolin-1, the integral 
membrane protein that serves as a scaffold and can regu-
late cell signaling pathways, is involved in chondrosenes-
cence; it has been reported to play a role in premature 
chondrocyte senescence induced by IL-1β and oxidative 
stress through the activation of p38 MAPK in human and 
rat models  [30] . Elevated levels of ROS can also contrib-
ute to reduced proteoglycan synthesis by causing an im-
balance in the activity of the PI3K/Akt and the ERK 
MAPK pathway in human chondrocytes, which have op-
posing roles in cartilage matrix production  [31] . Since the 
PI3K/Akt pathway plays important roles in regulating the 
chondrocyte cell cycle, proliferation, differentiation and 
apoptosis  [32] , and its activation increases proteoglycan 
synthesis in human chondrocytes  [33] , the age-related 
modulation of its activity may be an important contribu-
tor to chondrosenescence. Excessive ROS may also in-
hibit the insulin signaling pathway through activation of 
the stress-induced JNK in a human in vitro model  [34] .
 Senescent cells are known to exhibit altered activity and 
expression of regulatory proteins that control the cell cy-
cle, including p53 and the cyclin-dependent kinase inhib-
itors p21 CIP1 and p16 INK4A  [35] . Oxidative stress-induced 
PKCδ activation was reported to cooperate with the 
p16 INK4A retinoblastoma protein pathway in human cells 
to promote senescence  [36] . Oxidative stress is also known 
to reduce the activity of the calcium-calmodulin-depen-
dent phosphoprotein phosphatase calcineurin, which in-
terferes with the ERK pathway and Sox9 phosphorylation 
in a chicken micromass model  [37] . AMP-activated pro-
tein kinase (AMPK), a highly conserved sensor of in-
Aging
TGF-Ǆ
ALK5 ALK1
Smad2/3P
PAI-1
Smad1/5/8P
Id1
Loss of protective
Smad2/3 signaling  
Osteoarthritis
 Fig. 2. Alterations in TGF- β, ALK1/5, and Smad1/5/8 pathways in chondrocyte aging. Chondrosenescence re-
sults in a switch from the ALK5 to ALK1 pathway leading to the loss of protective Smad2/3 signaling in OA. 
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creased levels of AMP and ADP originating from ATP 
depletion  [38] , also has a role in aging as its sensitivity is 
reduced in aging tissues  [39] . Since a number of upstream 
protein kinases and phosphoprotein phosphatases are in-
volved in its regulation, it is possible that there are age-
related changes in the function of protein phosphatases, 
i.e. PP2A or PP2Cα, which could suppress AMPK activa-
tion with aging  [39] . Given its key role as an energy sensor 
in chondrocytes  [40] , AMPK is an emerging new target for 
preventing chondrosenescence and OA.  Figure 3 summa-
rizes our current understanding of the effects of chondro-
cyte aging on redox-sensitive protein kinase and phos-
phoprotein phosphatase signaling pathways.
 Conclusions and Future Directions 
 The incidence of OA is steadily rising across the world 
as the aging population grows. By 2037, it is estimated 
that the proportion of the population aged 70–90 years 
and beyond will expand significantly. Indeed, by the mid-
dle of this century, the proportion of centenarians in the 
United Kingdom and Europe will grow by more than 10-
fold. Therefore, health and social care systems across the 
globe need to prepare for the oncoming ‘tsunami’ of OA 
cases in the coming decades. Although aging is a non-
modifiable risk factor for the development of OA, there is 
clinical evidence to suggest that the risk for developing 
OA can be mitigated and reduced by lifestyle changes that 
involve weight management (i.e. weight loss and calorie 
restriction, avoiding obesity/overweight) and maintain-
ing high levels of mobility, thus avoiding the sedentary 
lifestyles that have become the root cause of most of the 
world’s healthcare issues. At the present time, there are 
no pharmacological agents available for the treatment of 
OA. A better understanding of the basic cell signaling 
mechanisms underlying aging in articular chondrocytes 
and other cell types in the joint is likely to facilitate the 
development of new therapeutic strategies for OA, spe-
cifically the development of disease-modifying osteoar-
Oxidative stress, increased levels of ROS
İ
Calcineurin
Sensitivity of AMPK
Chondrosenescence
Redox-sensitive PKs/PPPs
Aging
MMP activity
p38 MAPK
Stress-induced JNK
Imbalance in PI3K/Akt
and ERK1/2
3.&İ
 Fig. 3. Effects of chondrocyte aging on redox-sensitive protein kinase and phosphoprotein phosphatase signaling 
pathways. Oxidative stress and increased levels of ROS stimulate inflammatory and catabolic pathways, upregu-
late MMPs, and alter the activity of signaling pathways in chondrocytes. PPPs = Phosphoprotein phosphatases. 
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thritis drugs. In this regard, research on TGF-β signaling 
is more advanced than work on protein kinase and phos-
phoprotein phosphatase pathways in chondrocytes, and 
much more research is needed using both human and 
animal models to understand how calcium signaling and 
kinase/phosphatase activities are implicated in chondro-
cyte senescence in the context of OA pathogenesis and 
progression. Understanding deregulated cell signaling 
mechanisms in chondrocyte aging may also reveal thera-
peutic targets and pathways for a range of other age-re-
lated osteoarticular disorders. Aging is inevitable, but 
age-related diseases may be modifiable as long as we have 
a firm understanding of the molecular gerontology of 
chondrosenescence in OA. Future research should focus 
on humans and suitable animal models in order to de-
velop a unified ‘one health’ therapeutic solution to OA.
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